Related Experiment Video
Updated: Jan 27, 2026

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
Published on: January 31, 2020
HIV and cART-Associated Dyslipidemia Among HIV-Infected Children
Birkneh Tilahun Tadesse1,2, Byron Alexander Foster3, Adugna Chala4
1Department of Pediatrics, College of Medicine and Health Sciences, Hawassa University, Hawassa 1560, Ethiopia. birknehtilahun@gmail.com.
Insights
HIV-infected children on combination antiretroviral therapy (cART) show higher dyslipidemia rates, especially low HDLc and hypertriglyceridemia. Regular lipid monitoring is crucial for these children.
Area of Science:
- Pediatrics
- Infectious Diseases
- Cardiovascular Health
Background:
- Persistent dyslipidemia in children increases cardiovascular risks and impacts combination antiretroviral therapy (cART) outcomes.
- HIV-infected children are particularly vulnerable to dyslipidemia, influenced by both the virus and its treatment.
Purpose of the Study:
- To evaluate the prevalence and predictors of dyslipidemia in HIV-infected Ethiopian children.
- To compare dyslipidemia rates between children treatment-naïve and those on cART.
Main Methods:
- Enrolled 105 cART-naïve and 215 cART-experienced HIV-infected children from nine centers.
- Collected demographic, clinical, and lipid profile data, including cART type, adherence, and duration.
- Defined dyslipidemia using established cholesterol and triglyceride thresholds.
Main Results:
- Dyslipidemia prevalence was higher in cART-experienced (70.2%) versus treatment-naïve (58.1%) children.
- Low HDLc (40.2% vs. 23.4%) and hypertriglyceridemia (47.2% vs. 35.8%) were significantly more common in cART-experienced children.
- Nutrition status was linked to dyslipidemia in cART-naïve children.
Conclusions:
- A high prevalence of cART-associated dyslipidemia, particularly low HDLc and hypertriglyceridemia, exists in treatment-experienced HIV-infected children.
- These findings highlight the necessity of routine lipid monitoring for children undergoing cART.
Background:
Persistent dyslipidemia in children is associated with risks of cardiovascular accidents and poor combination antiretroviral therapy (cART) outcome. We report on the first evaluation of prevalence and associations with dyslipidemia due to HIV and cART among HIV-infected Ethiopian children.
Methods:
105 cART naïve and 215 treatment experienced HIV-infected children were enrolled from nine HIV centers. Demographic and clinical data, lipid profile, cART type, adherence to and duration on cART were recorded. Total, low density (LDLc) and high density (HDLc) cholesterol values >200 mg/dL, >130 mg/dL, <40 mg/dL, respectively; and/or, triglyceride values >150 mg/dL defined cases of dyslipidemia. Prevalence and predictors of dyslipidemia were compared between the two groups.
Results:
prevalence of dyslipidemia was significantly higher among cART experienced (70.2%) than treatment naïve (58.1%) children (p = 0.03). Prevalence of low HDLc (40.2% versus 23.4%, p = 0.006) and hypertriglyceridemia (47.2% versus 35.8%, p = 0.02) was higher among cART experienced than naïve children. There was no difference in total hypercholesterolemia and high LDLc levels. Nutrition state was associated with dyslipidemia among cART naïve children (p = 0.01).
Conclusion:
high prevalence of cART-associated dyslipidemia, particularly low HDLc and hypertriglyceridemia was observed among treatment experienced HIV-infected children. The findings underscore the need for regular follow up of children on cART for lipid abnormalities.
More Related Videos
Related Concept Videos
Drug Dosing: Infants and Children
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Stages of Infection
Sexually Transmitted Infections
Defense Mechanism Against Infection
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

